Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ArisGen SA

www.arisgen.com

Latest From ArisGen SA

ArisGen SA

ArisGen SA is tackling the two most persistent issues stymieing peptide drug development: overcoming the need for injection through an oral-delivery formulation and penetrating cell membranes to reach presently undruggable targets. The company has developed two unique platform technologies: a formulation series of precision polymers, which with appropriate excipients mask the active molecule’s functional groups allowing noninvasive drug absorption, and a reversible functionalization system enabling therapeutics to selectively penetrate across membrane barriers to reach the drug’s target inside the cell.
BioPharmaceutical

Start-Up Previews (09/2010)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Biotechs Target Cancer Metabolism," features profiles of Advanced Cancer Therapeutics, Cornerstone Pharmaceuticals and Dynamix Pharmaceuticals. Plus these Start-Ups Across Health Care: AlloCure, ArisGen, HistoSonics and NeuraviBiotechnology.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • ArisGen SA
  • Senior Management
  • Paolo Botti, PhD, CSO
  • Contact Info
  • ArisGen SA
    Phone: (41) 22 880 10 15
    14, Chemin des Aulx
    Geneva, CH-1228
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register